Combined effect of recombinant CD19xCD16 diabody and thalidomide in a preclinical model of human B cell lymphoma
Combining different treatment strategies offers the possibility of improving treatment results for cancer patients. The aim of our study was therefore to investigate the combination of treatment of established s.c. human B non-Hodgkin's lymphoma in severe immune deficient mice using a recombina...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
[October 2004]
|
| In: |
Anti-cancer drugs
Year: 2004, Volume: 15, Issue: 9, Pages: 915-919 |
| ISSN: | 1473-5741 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/anti-cancerdrugs/Fulltext/2004/10000/Combined_effect_of_recombinant_CD19_CD16_diabody.13.aspx
|
| Author Notes: | Jana Schlenzka, Thomas M. Moehler, Sergey M. Kipriyanov, Martin Kornacker, Axel Benner, Alexandra Bähre, Marike J. J. G. Stassar, Holger J. Schäfer, Melvyn Little, Hartmut Goldschmidt and Björn Cochlovius |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1793916969 | ||
| 003 | DE-627 | ||
| 005 | 20230928101732.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220225s2004 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1793916969 | ||
| 035 | |a (DE-599)KXP1793916969 | ||
| 035 | |a (OCoLC)1341445426 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schlenzka, Jana |d 1971- |e VerfasserIn |0 (DE-588)122728513 |0 (DE-627)70601782X |0 (DE-576)293397163 |4 aut | |
| 245 | 1 | 0 | |a Combined effect of recombinant CD19xCD16 diabody and thalidomide in a preclinical model of human B cell lymphoma |c Jana Schlenzka, Thomas M. Moehler, Sergey M. Kipriyanov, Martin Kornacker, Axel Benner, Alexandra Bähre, Marike J. J. G. Stassar, Holger J. Schäfer, Melvyn Little, Hartmut Goldschmidt and Björn Cochlovius |
| 246 | 3 | 3 | |a Combined effect of recombinant CD19×CD16 diabody and thalidomide in a preclinical model of human B cell lymphoma |
| 264 | 1 | |c [October 2004] | |
| 300 | |b Diagramme | ||
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 25.02.2022 | ||
| 520 | |a Combining different treatment strategies offers the possibility of improving treatment results for cancer patients. The aim of our study was therefore to investigate the combination of treatment of established s.c. human B non-Hodgkin's lymphoma in severe immune deficient mice using a recombinant bispecific CD19×CD16 diabody (targeting natural killer cells to CD19+ cells) and the angiogenesis inhibitor thalidomide. Monotherapy with either thalidomide or diabody caused an approximate 50% reduction in tumor growth rate. The combined treatment showed evidence for a synergistic effect resulting in a 74% reduction in median tumor size. In the combined treatment group, two of five animals had complete remissions of their s.c. tumor. These results suggest that a combination treatment with recombinant diabodies and angiogenesis inhibition represents a useful approach in cancer therapy. | ||
| 700 | 1 | |a Möhler, Thomas |e VerfasserIn |0 (DE-588)1014877261 |0 (DE-627)705298051 |0 (DE-576)34979572X |4 aut | |
| 700 | 1 | |a Kipriyanov, Sergey M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kornacker, Martin |d 1966- |e VerfasserIn |0 (DE-588)11573774X |0 (DE-627)691553858 |0 (DE-576)290048524 |4 aut | |
| 700 | 1 | |a Benner, Axel |d 1959- |e VerfasserIn |0 (DE-588)106584686X |0 (DE-627)81687221X |0 (DE-576)425536602 |4 aut | |
| 700 | 1 | |a Bähre, Alexandra |e VerfasserIn |0 (DE-588)1304094596 |0 (DE-627)1860341780 |4 aut | |
| 700 | 1 | |a Stassar, Marike J. J. G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schäfer, Holger |d 1969- |e VerfasserIn |0 (DE-588)1067525173 |0 (DE-627)818856912 |0 (DE-576)426714911 |4 aut | |
| 700 | 1 | |a Little, Melvyn |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Cochlovius, Björn |d 1968- |e VerfasserIn |0 (DE-588)120784084 |0 (DE-627)704985535 |0 (DE-576)292384033 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anti-cancer drugs |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1990 |g 15(2004), 9 vom: Okt., Seite 915-919 |h Online-Ressource |w (DE-627)320649652 |w (DE-600)2025803-3 |w (DE-576)094502161 |x 1473-5741 |7 nnas |a Combined effect of recombinant CD19xCD16 diabody and thalidomide in a preclinical model of human B cell lymphoma |
| 773 | 1 | 8 | |g volume:15 |g year:2004 |g number:9 |g month:10 |g pages:915-919 |g extent:5 |a Combined effect of recombinant CD19xCD16 diabody and thalidomide in a preclinical model of human B cell lymphoma |
| 856 | 4 | 0 | |u https://journals.lww.com/anti-cancerdrugs/Fulltext/2004/10000/Combined_effect_of_recombinant_CD19_CD16_diabody.13.aspx |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220225 | ||
| 993 | |a Article | ||
| 994 | |a 2004 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |d 50000 |e 910000PG102258023X |e 910100PG102258023X |e 50000PG102258023X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 10 | ||
| 998 | |g 1304094596 |a Bähre, Alexandra |m 1304094596:Bähre, Alexandra |d 140000 |e 140000PB1304094596 |k 0/140000/ |p 6 | ||
| 998 | |g 106584686X |a Benner, Axel |m 106584686X:Benner, Axel |p 5 | ||
| 998 | |g 11573774X |a Kornacker, Martin |m 11573774X:Kornacker, Martin |d 910000 |d 910100 |e 910000PK11573774X |e 910100PK11573774X |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1014877261 |a Möhler, Thomas |m 1014877261:Möhler, Thomas |d 910000 |d 910100 |e 910000PM1014877261 |e 910100PM1014877261 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 122728513 |a Schlenzka, Jana |m 122728513:Schlenzka, Jana |p 1 |x j | ||
| 999 | |a KXP-PPN1793916969 |e 4073418114 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"titleAlt":[{"title":"Combined effect of recombinant CD19×CD16 diabody and thalidomide in a preclinical model of human B cell lymphoma"}],"person":[{"family":"Schlenzka","display":"Schlenzka, Jana","given":"Jana","role":"aut"},{"role":"aut","given":"Thomas","family":"Möhler","display":"Möhler, Thomas"},{"display":"Kipriyanov, Sergey M.","family":"Kipriyanov","role":"aut","given":"Sergey M."},{"given":"Martin","role":"aut","family":"Kornacker","display":"Kornacker, Martin"},{"display":"Benner, Axel","family":"Benner","role":"aut","given":"Axel"},{"display":"Bähre, Alexandra","family":"Bähre","given":"Alexandra","role":"aut"},{"role":"aut","given":"Marike J. J. G.","family":"Stassar","display":"Stassar, Marike J. J. G."},{"given":"Holger","role":"aut","family":"Schäfer","display":"Schäfer, Holger"},{"family":"Little","display":"Little, Melvyn","role":"aut","given":"Melvyn"},{"role":"aut","given":"Hartmut","display":"Goldschmidt, Hartmut","family":"Goldschmidt"},{"given":"Björn","role":"aut","family":"Cochlovius","display":"Cochlovius, Björn"}],"recId":"1793916969","relHost":[{"language":["eng"],"part":{"issue":"9","text":"15(2004), 9 vom: Okt., Seite 915-919","year":"2004","pages":"915-919","extent":"5","volume":"15"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"320649652","id":{"eki":["320649652"],"zdb":["2025803-3"],"issn":["1473-5741"]},"pubHistory":["1.1990 -"],"origin":[{"publisherPlace":"Hagerstown, Md. ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1990-","publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedKey":"1990"}],"note":["Gesehen am 17.10.05"],"title":[{"title_sort":"Anti-cancer drugs","title":"Anti-cancer drugs"}],"disp":"Combined effect of recombinant CD19xCD16 diabody and thalidomide in a preclinical model of human B cell lymphomaAnti-cancer drugs","type":{"bibl":"periodical","media":"Online-Ressource"}}],"physDesc":[{"extent":"5 S.","noteIll":"Diagramme"}],"name":{"displayForm":["Jana Schlenzka, Thomas M. Moehler, Sergey M. Kipriyanov, Martin Kornacker, Axel Benner, Alexandra Bähre, Marike J. J. G. Stassar, Holger J. Schäfer, Melvyn Little, Hartmut Goldschmidt and Björn Cochlovius"]},"id":{"eki":["1793916969"]},"title":[{"title_sort":"Combined effect of recombinant CD19xCD16 diabody and thalidomide in a preclinical model of human B cell lymphoma","title":"Combined effect of recombinant CD19xCD16 diabody and thalidomide in a preclinical model of human B cell lymphoma"}],"note":["Gesehen am 25.02.2022"],"origin":[{"dateIssuedDisp":"[October 2004]","dateIssuedKey":"2004"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a SCHLENZKAJCOMBINEDEF2004 | ||